- 全部删除
 
您的购物车当前为空
Methyldopa hydrate (MK-351 hydrate) 是一种前药,在中枢神经系统中被代谢成 α-Methylepinephrine。它是一种 α-肾上腺素能激动剂,对α2-adrenergic receptors 有选择性。

Methyldopa hydrate (MK-351 hydrate) 是一种前药,在中枢神经系统中被代谢成 α-Methylepinephrine。它是一种 α-肾上腺素能激动剂,对α2-adrenergic receptors 有选择性。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 g | ¥ 119  | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 272  | In stock | 
Methyldopa hydrate 相关产品
| 产品描述 | Methyldopa hydrate (MK-351 hydrate) is a DOPA decarboxylase inhibitor and indirect α2-adrenergic receptor agonist used to treat hypertension. It inhibits the sympathetic nervous system, decreases production of dopamine, norepinephrine, and epinephrine, and exhibits NO-dependent sedative activity.  | 
| 分子量 | 238.24 | 
| 分子式 | C10H13NO4·3/2H2O | 
| CAS No. | 41372-08-1 | 
| Smiles | O.C[C@](N)(Cc1ccc(O)c(O)c1)C(O)=O | 
| 密度 | no data available | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 12 mg/mL (50.37 mM), Sonication is recommended.   | ||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (8.39 mM), Sonication is recommended.  请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||
溶液配制表  | |||||||||||||||||||||||||||||||
DMSO 
  | |||||||||||||||||||||||||||||||
评论内容